Cargando…

Late Stage of Corneal Decompensation Caused by Progressive Keratoconus: Can We Treat It and Save the Cornea?

Aim. To report a case of 40-year-old male with progressive bilateral keratoconus who had undergone transepithelial phototherapeutic keratectomy (TE-PTK) and corneal collagen cross-linking (CXL) using hypoosmolar riboflavin solution in a same day procedure. Methods. Eye examination showed that UCDVA...

Descripción completa

Detalles Bibliográficos
Autores principales: Knezović, Igor, Belovari Višnjić, Mirna, Raguž, Hrvoje
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430651/
https://www.ncbi.nlm.nih.gov/pubmed/26064737
http://dx.doi.org/10.1155/2015/795826
_version_ 1782371212154896384
author Knezović, Igor
Belovari Višnjić, Mirna
Raguž, Hrvoje
author_facet Knezović, Igor
Belovari Višnjić, Mirna
Raguž, Hrvoje
author_sort Knezović, Igor
collection PubMed
description Aim. To report a case of 40-year-old male with progressive bilateral keratoconus who had undergone transepithelial phototherapeutic keratectomy (TE-PTK) and corneal collagen cross-linking (CXL) using hypoosmolar riboflavin solution in a same day procedure. Methods. Eye examination showed that UCDVA on both eyes was 0,01 according to Snellen charts, and slit lamp biomicroscopy showed paracentral diffuse intrastromal corneal haze. Anterior OCT marked stromal hyperreflective zones and localized paracentral thinning of the cornea. Scheimpflug tomography noted keratoconus stages III-IV on both eyes. After 40/35 microns TE-PTK, a CXL was performed for 30 minutes using hypoosmolar riboflavin solution. The left eye was treated first and the right eye 1 month after. Follow-up period was 10 months. Results. One month after the treatment both eyes showed improvement in corneal topography and the UCDVA was better. Eight months after the treatment BSCVA improved to 0,6 in both eyes using Rose K2 contact lenses and remained stable. Conclusion. TE-PTK and CXL using hypotonic riboflavin solution as a same day procedure have been shown to be a safe and promising method in this case of progressive keratoconus. It was necessary to consider certain parameters that could influence the safety and the final outcome of this combined protocol.
format Online
Article
Text
id pubmed-4430651
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-44306512015-06-10 Late Stage of Corneal Decompensation Caused by Progressive Keratoconus: Can We Treat It and Save the Cornea? Knezović, Igor Belovari Višnjić, Mirna Raguž, Hrvoje Case Rep Ophthalmol Med Case Report Aim. To report a case of 40-year-old male with progressive bilateral keratoconus who had undergone transepithelial phototherapeutic keratectomy (TE-PTK) and corneal collagen cross-linking (CXL) using hypoosmolar riboflavin solution in a same day procedure. Methods. Eye examination showed that UCDVA on both eyes was 0,01 according to Snellen charts, and slit lamp biomicroscopy showed paracentral diffuse intrastromal corneal haze. Anterior OCT marked stromal hyperreflective zones and localized paracentral thinning of the cornea. Scheimpflug tomography noted keratoconus stages III-IV on both eyes. After 40/35 microns TE-PTK, a CXL was performed for 30 minutes using hypoosmolar riboflavin solution. The left eye was treated first and the right eye 1 month after. Follow-up period was 10 months. Results. One month after the treatment both eyes showed improvement in corneal topography and the UCDVA was better. Eight months after the treatment BSCVA improved to 0,6 in both eyes using Rose K2 contact lenses and remained stable. Conclusion. TE-PTK and CXL using hypotonic riboflavin solution as a same day procedure have been shown to be a safe and promising method in this case of progressive keratoconus. It was necessary to consider certain parameters that could influence the safety and the final outcome of this combined protocol. Hindawi Publishing Corporation 2015 2015-04-30 /pmc/articles/PMC4430651/ /pubmed/26064737 http://dx.doi.org/10.1155/2015/795826 Text en Copyright © 2015 Igor Knezović et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Knezović, Igor
Belovari Višnjić, Mirna
Raguž, Hrvoje
Late Stage of Corneal Decompensation Caused by Progressive Keratoconus: Can We Treat It and Save the Cornea?
title Late Stage of Corneal Decompensation Caused by Progressive Keratoconus: Can We Treat It and Save the Cornea?
title_full Late Stage of Corneal Decompensation Caused by Progressive Keratoconus: Can We Treat It and Save the Cornea?
title_fullStr Late Stage of Corneal Decompensation Caused by Progressive Keratoconus: Can We Treat It and Save the Cornea?
title_full_unstemmed Late Stage of Corneal Decompensation Caused by Progressive Keratoconus: Can We Treat It and Save the Cornea?
title_short Late Stage of Corneal Decompensation Caused by Progressive Keratoconus: Can We Treat It and Save the Cornea?
title_sort late stage of corneal decompensation caused by progressive keratoconus: can we treat it and save the cornea?
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430651/
https://www.ncbi.nlm.nih.gov/pubmed/26064737
http://dx.doi.org/10.1155/2015/795826
work_keys_str_mv AT knezovicigor latestageofcornealdecompensationcausedbyprogressivekeratoconuscanwetreatitandsavethecornea
AT belovarivisnjicmirna latestageofcornealdecompensationcausedbyprogressivekeratoconuscanwetreatitandsavethecornea
AT raguzhrvoje latestageofcornealdecompensationcausedbyprogressivekeratoconuscanwetreatitandsavethecornea